Solid Biosciences Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Solid Biosciences Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q4 2018 to Q4 2023.
  • Solid Biosciences Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending December 31, 2023 was $4.12M, a 0.76% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.12M +$31K +0.76% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $4.09M Dec 31, 2022 10-K 2023-03-23
Q4 2020 $686K -$738K -51.8% Dec 31, 2020 10-K 2021-03-15
Q4 2019 $1.42M -$632K -30.7% Dec 31, 2019 10-K 2020-03-12
Q3 2019 $2.44M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.44M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $2.45M Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $2.06M Dec 31, 2018 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.